Lalit K. Golani - Concepedia

Author

Lalit K. Golani

University of Wisconsin–Milwaukee ORCID

Also Known As

L.K. Golani, Lalit Golani, Lalit K Golani, Lalit K. Golani, Lalit Kumar Golani

Publications

550

Citations

H-Index

Concepts

All Affiliations

University of Wisconsin–Milwaukee St. Vincent Hospital Indiana University – Purdue University Indianapolis Wayne State University Northeastern University

About

Lalit K. Golani is an author at University of Wisconsin–Milwaukee specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	156
2	Health Sciences	2	2	52
3	Biochemistry	2	2	46
4	Natural Sciences	1	1	31
5	Chemical Biology	1	1	12

Lalit K. Golani

Publications

330

Citations

H-Index

Page 1

	Year	Citations
The α2,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats Jeffrey M. Witkin, Rok Cerne, Paula G. Davis, Pharmacology Biochemistry and Behavior Pain MedicineSynaptic TransmissionNeuromodulation TherapiesAnesthetic MechanismMolecular Pain	2019	33
Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-<i>d</i>] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis Lalit K. Golani, Adrianne Wallace-Povirk, S.M. Deis, Journal of Medicinal Chemistry Pharmaceutical ChemistryTumor BiologyMedicinal ChemistryCarbon VicinalCellular Uptake	2016	31
Structure–Activity Profiles of Novel 6-Substituted Pyrrolo[2,3-<i>d</i>]pyrimidine Thienoyl Antifolates with Modified Amino Acids for Cellular Uptake by Folate Receptors α and β and the Proton-Coupled Folate Transporter Lalit K. Golani, Christina George, Sai Zhao, Journal of Medicinal Chemistry	2014	26
The Positive Allosteric Modulator of α2/3-Containing GABAA Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury Jeffrey M. Witkin, Guanguan Li, Lalit K. Golani, Journal of Pharmacology and Experimental Therapeutics	2019	26
(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders Hana Shafique, Julie Demers, Julia Biesiada, International Journal of Molecular Sciences	2024	22
Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam Megan J. Moerke, Guanguan Li, Lalit K. Golani, Behavioural Pharmacology Pain DisordersPain MedicineNeuromodulation TherapiesMolecular PainAcid-induced Icss Depression	2019	19
Clinical pharmacological innovation in the treatment of depression Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith Expert Review of Clinical Pharmacology	2023	18
Papaverine ameliorates prenatal alcohol‐induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stress Niti Sharma, Neerupma Dhiman, Lalit K. Golani, International Journal of Developmental Neuroscience	2020	17
An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA A receptors Kashi Reddy Methuku, X Li, Rok Cerne, Pharmacology Biochemistry and Behavior Molecular PharmacologyPsychiatryMedicinePositive Allosteric ModulatorsPsychotropic Medication	2018	16
The α2,3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance development Andrew Biggerstaff, Bronwyn M. Kivell, Jodi L. Smith, Pharmacology Biochemistry and Behavior Medicineα2,3-Selective PotentiatorsImmunologyMechanism Of ActionPharmacological Agent	2020	16

Page 1